Endoscopic Sinus Surgery in Adults With Cystic Fibrosis

Authors:

Abstract
Cystic fibrosis (CF) is a systemic disease with autosomal recessive inheritance that affects exocrine gland function. Affecting more than 24 000 individuals in the United States as of 2006,1 CF is the most common life-shortening inherited disease in white populations.2 The CFTR gene (OMIM 602421), the gene responsible for changes seen in the disease, was identified in 1989 and is located on the long arm of chromosome 7.3-6 Its mutation results in abnormal synthesis of the CFTR protein, which functions as an ion channel across the apical surface of the epithelial cell membrane and is primarily found in tissues that produce sweat, mucus, saliva, tears, and digestive enzymes. This mutation results in abnormal chloride transport through the cell membrane and, as a consequence, chloride and sodium transport across the epithelium. Expression of mutant CFTR in the respiratory tract (including the sinuses) results in the triad of altered mucociliary clearance, a markedly exaggerated inflammatory response, and chronic bacterial infection.7 The most common cause of death (in >80% of cases) in CF patients today is progressive bronchiectasis and ultimately respiratory failure. Sinonasal disease in the form of chronic rhinosinusitis, with or without nasal polyposis, has a significant incidence in the CF population. Radiologic findings of paranasal sinus opacification on computed tomography can be found in almost every patient with CF, with a reported incidence of nasal polyposis between 33% and 57%.8-11 Exacerbations of rhinosinusitis in CF are thought to contribute to pulmonary exacerbations and frequently require treatment with intravenous (IV) antibiotics, especially in the adult CF population. Therefore, adequate control of sinus symptoms in this population is necessary.

This publication has 20 references indexed in Scilit: